SubHero Banner
Text

September 2018

Core topics in this month’s edition include:

  • Ajovy (fremanezumab-vfrm) - new drug approval
  • Cialis (tadalafil) - first time generic
  • Emgality (galcanezumab-gnlm) - new drug approval
  • Valsartan-containing products - recall update

Download PDF

Text